Sign in →

Test Code LAB788 Lyme Disease Serology, IgG and IgM, Serum

Reporting Title

Lyme Disease

Methodology

Diasorin LIAISON®, Competitive Two-Step Chemiluminescence Assay

Note:  Positive results will be confirmed by Western blot at an additional charge.

Useful for determination of serologic evidence of infection with Borrelia burgdorferi.

Performing Laboratory

OhioHealth Laboratory Services-RMH Special Testing

Specimen Requirements

Draw blood in a gold-top serum gel tube(s). Spin down and send 1.5 mL (pediatric volume:  0.2 mL) of serum refrigerated.

Note:  A speckled-top serum gel tube (s) or a plain, red-top tube(s) is also acceptable.

 

Specimen Stability Information

Specimen Type Temperature Time
Serum Refrigerated 7 days
  Ambient   
  Frozen  Stable

 

Specimen Transport Temperature

Refrigerate/Ambient OK/Frozen OK

Reference Values

Negative

Patients with symptoms of Lyme disease and negative results should be retested in 4 to 6 weeks. Patients in early stages of disease or those who have received antibiotics may not produce measurable antibodies. Crossreactivity may occur with relapsing fever, Rocky Mountain spotted fever (Rickettsia rickettsii), spirochete diseases, rheumatoid arthritis, systemic lupus erythematous, Epstein-Barr virus, cytomegalovirus, or syphilis, therefore, positive results are confirmed with Western blot assay.

Day(s) Test Set Up

Monday through Friday 24/7

Saturday and Sunday day shift only

Test Classification and CPT Coding

86618 - Lyme disease

86617 x 2 - Western blot (if appropriate)